Product
Diclofenac Sodium
Aliases
Diclofenac Sodium 3% Gel, Diclofenac Sodium Gel
5 clinical trials
7 indications
Indication
HealthyIndication
KeratosisIndication
ActinicIndication
Trauma InjuryIndication
InflammationIndication
UrolithiasisIndication
Acute Postoperative PainClinical trial
A Phase 1, Single-Center, Randomized, Open-Label, Bioavailability and Safety Three Period Crossover Multiple-Dose Study Comparing Two Dose Levels of AMZ001 (Diclofenac Sodium Gel 3.06%) and One Dose Level of Diclofenac Sodium 1% Gel in Healthy SubjectsStatus: Active (not recruiting), Estimated PCD: 2023-12-27
Clinical trial
A Phase 4, Multi-centre, Randomized, Evaluator-blinded, Active-controlled Study to Determine the Incidence of Squamous Cell Carcinoma and Evaluate the Long-term Safety of Tirbanibulin 10 mg/g Ointment and Diclofenac Sodium 3% Gel for the Treatment of Adult Patients With Actinic Keratosis on the Face or ScalpStatus: Recruiting, Estimated PCD: 2027-03-01
Clinical trial
Randomized, Double Blind, Parallel-groups, Non-inferiority Versus Flector® and Superiority Versus Placebo, Phase III Clinical Trial With Diclofenac Sodium 140 mg Medicated Plaster in Patients With Impact Injuries of the LimbsStatus: Completed, Estimated PCD: 2018-10-27
Clinical trial
Comparison Between Intracutaneous Sterile Water and Diclofenac Sodium Injections in Renal Colic: A Randomized Controlled Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2024-10-30
Clinical trial
Various Strategies to Reduce Acute Post Hemorrhoidectomy Pain: A Comparative StudyStatus: Active (not recruiting), Estimated PCD: 2024-07-14